(Q34561527)

3 August 2017

1 reference

title

Mechanisms of the antitumoral effect of lipid A. (English)

1 reference

3 August 2017

Danièle Reisser

1

1 reference

3 August 2017

Alena Pance

series ordinal

2

1 reference

3 August 2017

Jean-François Jeannin

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

3 August 2017

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

284-289

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

3 August 2017

1 reference

Adjuvant and antitumour activities of synthetic lipid A analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Inhibition of tumor-induced angiogenesis by a synthetic lipid A analogue with low endotoxicity, DT-5461.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Involvement of T lymphocytes in curative effect of a new immunomodulator OM 163 on rat colon cancer metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Correlation between the capacity to activate macrophages in vitro and the antitumor activity in vivo of lipopolysaccharides from different bacterial species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Lipid A and the lipid A analogue anti-tumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Phase II trial of intravenous endotoxin in patients with colorectal and non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Intradermal administration of lipopolysaccharide in treatment of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Phase-I study of intravenous modified lipid A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Active specific immunotherapy of melanoma with allogeneic cell lysates. Rationale, results, and possible mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIES.10053

21 January 2018

Identifiers

DOI

10.1002/BIES.10053

1 reference

3 August 2017

1 reference